Published in Hum Reprod Update on May 25, 2009
Early menopausal hormone use influences brain regions used for visual working memory. Menopause (2010) 1.67
Does lifetime exposure to hormones predict pretreatment cognitive function in women before adjuvant therapy for breast cancer? Menopause (2013) 1.46
Mild cognitive impairment and dementia: the importance of modifiable risk factors. Dtsch Arztebl Int (2011) 1.43
Menopause-associated symptoms and cognitive performance: results from the study of women's health across the nation. Am J Epidemiol (2010) 1.22
Estrogen and cognitive functioning in women: lessons we have learned. Behav Neurosci (2011) 1.10
Synaptic estrogen receptor-alpha levels in prefrontal cortex in female rhesus monkeys and their correlation with cognitive performance. J Neurosci (2010) 1.09
Perimenopausal use of hormone therapy is associated with enhanced memory and hippocampal function later in life. Brain Res (2010) 1.08
Interactive effects of age and estrogen on cortical neurons: implications for cognitive aging. Neuroscience (2011) 1.06
Summary of the National Institute on Aging-sponsored conference on depressive symptoms and cognitive complaints in the menopausal transition. Menopause (2010) 1.00
Postmenopausal hormone therapy, timing of initiation, APOE and cognitive decline. Neurobiol Aging (2010) 1.00
Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on. Climacteric (2012) 1.00
Long-term effects of conjugated equine estrogen therapies on domain-specific cognitive function: results from the Women's Health Initiative study of cognitive aging extension. J Am Geriatr Soc (2010) 1.00
Quality of life issues in men undergoing androgen deprivation therapy: a review. Asian J Androl (2012) 0.95
Perimenopause and cognition. Obstet Gynecol Clin North Am (2011) 0.94
Cognitive changes associated with ADT: a review of the literature. Asian J Androl (2012) 0.91
The cognitive effects of conjugated equine estrogens depend on whether menopause etiology is transitional or surgical. Endocrinology (2010) 0.90
Differences in verbal memory performance in postmenopausal women receiving hormone therapy: 17β-estradiol versus conjugated equine estrogens. Am J Geriatr Psychiatry (2011) 0.87
Women and HIV infection: the makings of a midlife crisis. Maturitas (2009) 0.87
Early androgen effects on spatial and mechanical abilities: evidence from congenital adrenal hyperplasia. Behav Neurosci (2012) 0.86
Hormone replacement therapy and risk for neurodegenerative diseases. Int J Alzheimers Dis (2012) 0.86
Cognitive response to estradiol in postmenopausal women is modified by high cortisol. Neurobiol Aging (2011) 0.79
Effects of diosgenin on myometrial matrix metalloproteinase-2 and -9 activity and expression in ovariectomized rats. Int J Biol Sci (2011) 0.78
Oestrogen receptor polymorphisms are an associated risk factor for mild cognitive impairment and Alzheimer disease in women APOE {varepsilon}4 carriers: a case-control study. BMJ Open (2013) 0.78
The Chinese version of story recall: a useful screening tool for mild cognitive impairment and Alzheimer's disease in the elderly. BMC Psychiatry (2014) 0.78
An NO donor approach to neuroprotective and procognitive estrogen therapy overcomes loss of NO synthase function and potentially thrombotic risk. PLoS One (2013) 0.77
Longer duration of hormonal contraceptive use predicts better cognitive outcomes later in life. J Womens Health (Larchmt) (2012) 0.77
Menopausal Symptoms and Their Management. Endocrinol Metab Clin North Am (2015) 0.77
Continuously delivered ovarian steroids do not alter dendritic spine density or morphology in macaque dorsolateral prefrontal cortical neurons. Neuroscience (2013) 0.77
Neuropsychology of Neuroendocrine Dysregulation after Traumatic Brain Injury. J Clin Med (2015) 0.76
Distinct cognitive effects of estrogen and progesterone in menopausal women. Psychoneuroendocrinology (2015) 0.75
Hormone therapy at early post-menopause increases cognitive control-related prefrontal activity. Sci Rep (2017) 0.75
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology (1989) 16.83
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA (2007) 10.50
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet (1996) 7.10
Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA (2002) 6.72
An application of prefrontal cortex function theory to cognitive aging. Psychol Bull (1996) 5.89
Effects of estrogen plus progestin on health-related quality of life. N Engl J Med (2003) 4.83
Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology (2007) 4.28
Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA (2004) 3.85
Preclinical prediction of AD using neuropsychological tests. J Int Neuropsychol Soc (2001) 3.62
Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry (2006) 3.44
Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology (1995) 3.37
Medial temporal lobe activations in fMRI and PET studies of episodic encoding and retrieval. Hippocampus (1999) 3.00
Maintenance versus manipulation of information held in working memory: an event-related fMRI study. Brain Cogn (1999) 2.93
Neuropsychological measures in normal individuals that predict subsequent cognitive decline. Arch Neurol (2007) 2.77
Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons. J Neurosci (1990) 2.75
Acute effects of estrogen on neuronal physiology. Annu Rev Pharmacol Toxicol (2007) 2.67
Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years. Neurology (2005) 2.45
The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. Arch Neurol (1995) 2.42
Cyclic estrogen replacement improves cognitive function in aged ovariectomized rhesus monkeys. J Neurosci (2003) 2.40
Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism. J Neurosci (1994) 2.33
Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA (2001) 2.32
KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric (2005) 2.32
Modulation of cognition-specific cortical activity by gonadal steroids: a positron-emission tomography study in women. Proc Natl Acad Sci U S A (1997) 2.19
Hormone therapy and risk of Alzheimer disease: a critical time. JAMA (2002) 2.16
Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA (1998) 2.14
Objective hot flashes are negatively related to verbal memory performance in midlife women. Menopause (2008) 2.14
The Women's Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Control Clin Trials (1998) 2.09
Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats. Neurobiol Aging (2000) 2.08
Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology (1992) 2.05
Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab (2006) 2.03
Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study. Am J Med (2002) 2.02
Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology (2002) 2.01
Neural bases of learning and memory: functional neuroimaging evidence. Curr Opin Neurol (2000) 2.01
Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology (1988) 1.99
"Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J Clin Endocrinol Metab (1996) 1.98
Preclinical Alzheimer disease: neuropsychological test performance 1.5 to 8 years prior to onset. Neurology (2004) 1.87
Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling. Proc Natl Acad Sci U S A (2003) 1.77
Hot flashes and estrogen therapy do not influence cognition in early menopausal women. Menopause (2007) 1.76
Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA (1999) 1.73
Functional neuroanatomical double dissociation of mnemonic and executive control processes contributing to working memory performance. Proc Natl Acad Sci U S A (1999) 1.72
Sixteen-year longitudinal and time lag changes in memory and cognition in older adults. Psychol Aging (1997) 1.68
Maintenance versus manipulation in verbal working memory revisited: an fMRI study. Neuroimage (2003) 1.63
Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol (1997) 1.63
Ovarian steroids and the brain: implications for cognition and aging. Neurology (1997) 1.63
Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful. J Neurol Neurosurg Psychiatry (2003) 1.60
Frontal lobe damage produces episodic memory impairment. J Int Neuropsychol Soc (1995) 1.59
Effectiveness of estrogen replacement in restoration of cognitive function after long-term estrogen withdrawal in aging rats. J Neurosci (2002) 1.50
Prefrontal cortex as the site of estrogen's effect on cognition. Psychoneuroendocrinology (2001) 1.48
Estrogen replacement increases spinophilin-immunoreactive spine number in the prefrontal cortex of female rhesus monkeys. Cereb Cortex (2004) 1.48
Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy. Am J Psychiatry (2001) 1.44
Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol Aging (2000) 1.43
Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial. Neurology (2007) 1.43
Estradiol increases the frequency of multiple synapse boutons in the hippocampal CA1 region of the adult female rat. J Comp Neurol (1996) 1.39
General and specific brain regions involved in encoding and retrieval of events: what, where, and when. Proc Natl Acad Sci U S A (1996) 1.38
Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research. Neuroscience (2005) 1.38
Longitudinal changes in verbal memory in older adults: distinguishing the effects of age from repeat testing. Neurology (2003) 1.38
Hormone therapy and cognitive function: is there a critical period for benefit? Neuroscience (2006) 1.36
Ovariectomized rats show decreased recognition memory and spine density in the hippocampus and prefrontal cortex. Brain Res (2006) 1.35
Sex steroids modify working memory. J Cogn Neurosci (2000) 1.34
Identifying regional activity associated with temporally separated components of working memory using event-related functional MRI. Neuroimage (2003) 1.31
Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res (1994) 1.30
Estrogen replacement enhances acquisition of a spatial memory task and reduces deficits associated with hippocampal muscarinic receptor inhibition. Horm Behav (1999) 1.30
Estradiol interacts with the cholinergic system to affect verbal memory in postmenopausal women: evidence for the critical period hypothesis. Horm Behav (2007) 1.30
Estrogen and cognition: applying preclinical findings to clinical perspectives. J Neurosci Res (2003) 1.27
Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance. Horm Behav (1998) 1.27
A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life. Neurobiol Aging (2005) 1.24
A beneficial effect of estrogen on working memory in postmenopausal women taking hormone replacement therapy. Horm Behav (2000) 1.23
Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci U S A (1992) 1.23
Memory functioning among midlife women: observations from the Seattle Midlife Women's Health Study. Menopause (2000) 1.23
Impact of progestins on estradiol potentiation of the glutamate calcium response. Neuroreport (2002) 1.22
Interactive effects of fitness and hormone treatment on brain health in postmenopausal women. Neurobiol Aging (2006) 1.19
Midlife women's attributions about perceived memory changes: observations from the Seattle Midlife Women's Health Study. J Womens Health Gend Based Med (2001) 1.19
Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain. Exp Gerontol (1994) 1.10
Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life. Arch Neurol (2006) 1.10
The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females. Psychopharmacology (Berl) (2000) 1.09
Estrogen treatment effects on anticholinergic-induced cognitive dysfunction in normal postmenopausal women. Neuropsychopharmacology (2006) 1.08
Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol (1991) 1.07
Use of menopausal estrogens and medroxyprogesterone in the United States, 1982-1992. Obstet Gynecol (1995) 1.07
Ovarian steroids and serotonin neural function. Mol Neurobiol (1998) 1.04
Acquisition, recall, and forgetting of verbal information in long-term memory by young, middle-aged, and elderly individuals. Cortex (2003) 1.04
The prevalence of the neuropathological lesions of Alzheimer's disease is independent of race and gender. Neurobiol Aging (2001) 1.03
Effects of treatment with leuprolide acetate depot on working memory and executive functions in young premenopausal women. Psychoneuroendocrinology (2006) 1.02
Effects of hormone replacement therapy on cognitive performance in elderly women. Maturitas (2001) 1.02
Better oral reading and short-term memory in midlife, postmenopausal women taking estrogen. Menopause (2003) 1.01
Estrogen therapy and risk of cognitive decline: results from the Women's Estrogen for Stroke Trial (WEST). Am J Obstet Gynecol (2005) 1.00
Effects of estrogen on patterns of brain activity at rest and during cognitive activity: a review of neuroimaging studies. Neuroimage (2001) 0.99
The effect of short-term estrogen replacement therapy on cognition: a randomized, double-blind, cross-over trial in postmenopausal women. Obstet Gynecol (1998) 0.98
Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J Affect Disord (1988) 0.96
Age and gender interactions on verbal memory performance. J Int Neuropsychol Soc (2003) 0.96
Effects of hormone replacement therapy and aging on cognition: evidence for executive dysfunction. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (2007) 0.95
Estradiol and testosterone in specific regions of the human female brain in different endocrine states. J Steroid Biochem Mol Biol (1995) 0.93
Effect of estradiol and soy phytoestrogens on choline acetyltransferase and nerve growth factor mRNAs in the frontal cortex and hippocampus of female rats. Proc Soc Exp Biol Med (1999) 0.93
Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients. Arzneimittelforschung (2001) 0.92
Short-term transdermal estradiol therapy, cognition and depressive symptoms in healthy older women. A randomised placebo controlled pilot cross-over study. Psychoneuroendocrinology (2004) 0.92
The effect of 3-year treatment with 0.25 mg/day of micronized 17beta-estradiol on cognitive function in older postmenopausal women. J Am Geriatr Soc (2007) 0.91
Two weeks of transdermal estradiol treatment in postmenopausal elderly women and its effect on memory and mood: verbal memory changes are associated with the treatment induced estradiol levels. Psychoneuroendocrinology (1999) 0.90
Gonadotropin hormone releasing hormone agonists alter prefrontal function during verbal encoding in young women. Psychoneuroendocrinology (2007) 0.89